Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 1
1948 1
1949 4
1950 1
1952 1
1953 2
1954 3
1956 1
1958 1
1959 2
1960 2
1961 1
1962 2
1963 1
1964 1
1967 1
1968 1
1971 1
1972 1
1973 2
1974 1
1975 1
1977 1
1978 4
1979 4
1980 10
1981 3
1982 6
1983 8
1984 20
1985 20
1986 24
1987 34
1988 45
1989 55
1990 60
1991 59
1992 52
1993 50
1994 69
1995 60
1996 68
1997 100
1998 92
1999 99
2000 109
2001 90
2002 103
2003 110
2004 113
2005 117
2006 114
2007 153
2008 141
2009 154
2010 160
2011 189
2012 187
2013 179
2014 187
2015 188
2016 177
2017 199
2018 219
2019 191
2020 260
2021 239
2022 235
2023 227
2024 93

Text availability

Article attribute

Article type

Publication date

Search Results

4,692 results

Results by year

Filters applied: . Clear all
Page 1
Recent Advances in Castleman Disease.
Hoffmann C, Hentrich M, Tiemann M, Rosenwald A, Weber F, Willenbacher W, Hübel K. Hoffmann C, et al. Oncol Res Treat. 2022;45(11):693-704. doi: 10.1159/000526640. Epub 2022 Oct 11. Oncol Res Treat. 2022. PMID: 36219975 Review.
BACKGROUND: Castleman disease (CD) encompasses a spectrum of rare disorders with characteristic histopathological features. ...KEY MESSAGES: We herein summarize recent advances in diagnosis, treatment, and novel insights into the pathogenesis of this disease. …
BACKGROUND: Castleman disease (CD) encompasses a spectrum of rare disorders with characteristic histopathological features. .. …
Castleman Disease.
van Rhee F, Munshi NC. van Rhee F, et al. Hematol Oncol Clin North Am. 2018 Feb;32(1):xiii-xiv. doi: 10.1016/j.hoc.2017.10.001. Hematol Oncol Clin North Am. 2018. PMID: 29157623 No abstract available.
Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis.
González García A, Fernández-Martín J, Robles Marhuenda Á. González García A, et al. Rheumatology (Oxford). 2023 Apr 3;62(4):1426-1435. doi: 10.1093/rheumatology/keac481. Rheumatology (Oxford). 2023. PMID: 35997567 Free PMC article. Review.
Idiopathic multicentric Castleman disease (iMCD) is an infrequent and life-threatening disorder characterized by systemic inflammatory symptoms, generalized lymphadenopathy, polyclonal lymphocyte proliferation and organ dysfunction caused by a hyperinflammatory stat …
Idiopathic multicentric Castleman disease (iMCD) is an infrequent and life-threatening disorder characterized by systemic infl …
Unicentric Castleman Disease.
Wong RSM. Wong RSM. Hematol Oncol Clin North Am. 2018 Feb;32(1):65-73. doi: 10.1016/j.hoc.2017.09.006. Hematol Oncol Clin North Am. 2018. PMID: 29157620 Review.
Unicentric Castleman disease (UCD) is a rare lymphoproliferative disorder that manifests typically as proliferation of a single lymph node or region of lymph nodes. ...
Unicentric Castleman disease (UCD) is a rare lymphoproliferative disorder that manifests typically as proliferation of a singl …
Pathology of Castleman Disease.
Wu D, Lim MS, Jaffe ES. Wu D, et al. Hematol Oncol Clin North Am. 2018 Feb;32(1):37-52. doi: 10.1016/j.hoc.2017.09.004. Hematol Oncol Clin North Am. 2018. PMID: 29157618 Review.
The term Castleman disease encompasses several distinct lymphoproliferative disorders with different underlying disease pathogenesis, and clinical outcomes. ...An overview of the key histopathologic features of Castleman disease is presented....
The term Castleman disease encompasses several distinct lymphoproliferative disorders with different underlying disease …
[Castleman disease].
Szturz P, Moulis M, Adam Z, Slaisová R, Koukalová R, Rehák Z, Volfová P, Hájek R, Mayer J. Szturz P, et al. Klin Onkol. 2011;24(6):424-34. Klin Onkol. 2011. PMID: 22257231 Review. Czech.
BACKGROUNDS: Castleman disease is a rare non-clonal lymphoproliferative disorder with the etiopathogenesis not yet thoroughly clarified. ...AIM: The paper provides an overview of information on Castleman disease from its clinical and histopathological …
BACKGROUNDS: Castleman disease is a rare non-clonal lymphoproliferative disorder with the etiopathogenesis not yet thoroughly …
Multicentric Castleman disease: Where are we now?
Wang HW, Pittaluga S, Jaffe ES. Wang HW, et al. Semin Diagn Pathol. 2016 Sep;33(5):294-306. doi: 10.1053/j.semdp.2016.05.006. Epub 2016 May 16. Semin Diagn Pathol. 2016. PMID: 27296355 Free PMC article. Review.
Multicentric Castleman disease (MCD) encompasses a spectrum of conditions that give rise to overlapping clinicopathological manifestations. ...The histological changes in lymph nodes resemble in part the findings originally described in the unicentric forms Castl …
Multicentric Castleman disease (MCD) encompasses a spectrum of conditions that give rise to overlapping clinicopathological ma …
Castleman's disease.
Shahidi H, Myers JL, Kvale PA. Shahidi H, et al. Mayo Clin Proc. 1995 Oct;70(10):969-77. doi: 10.4065/70.10.969. Mayo Clin Proc. 1995. PMID: 7564550 Review.
OBJECTIVE: To describe the two variants of Castleman's disease--the hyaline-vascular type and the plasma-cell type--and discuss the associated histologic features. DESIGN: We present a case of the hyaline-vascular type and review the literature. RESULTS: Castlema …
OBJECTIVE: To describe the two variants of Castleman's disease--the hyaline-vascular type and the plasma-cell type--and discus …
A Rare Lymphoproliferative Disease: Castleman Disease.
Gündüz E, Özdemir N, Bakanay ŞM, Karakuş S. Gündüz E, et al. Turk J Haematol. 2021 Dec 7;38(4):314-320. doi: 10.4274/tjh.galenos.2021.2021.0440. Epub 2021 Nov 1. Turk J Haematol. 2021. PMID: 34719151 Free PMC article.
Castleman disease is a rare lymphoproliferative disease also known as angiofollicular lymph node hyperplasia. ...Several malignant diseases including lymphomas, POEMS syndrome, follicular dendritic cell sarcomas, paraneoplastic pemphigus, Kaposi sarcoma, and …
Castleman disease is a rare lymphoproliferative disease also known as angiofollicular lymph node hyperplasia. ...Severa …
Osteosclerosis in Castleman's disease.
Liu SZ, Zhou X, Wang YP, Liu Y. Liu SZ, et al. QJM. 2022 Mar 22;115(3):171-172. doi: 10.1093/qjmed/hcac013. QJM. 2022. PMID: 35088859 No abstract available.
4,692 results

Searches related to "castleman disease"